These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 24029475)
1. [Experimental autoimmune model of muscle-specific kinase specific myasthenia gravis in rats]. Chen Y; Wang HB; Wang YJ Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1292-6. PubMed ID: 24029475 [TBL] [Abstract][Full Text] [Related]
2. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK. Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354 [TBL] [Abstract][Full Text] [Related]
3. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase]. Maruyama N; Shigemoto K Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis. Lazaridis K; Baltatzidou V; Tektonidis N; Tzartos SJ J Neuroimmunol; 2020 Feb; 339():577136. PubMed ID: 31855721 [TBL] [Abstract][Full Text] [Related]
5. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis. Li Z; Li M; Wood K; Hettwer S; Muley SA; Shi FD; Liu Q; Ladha SS Muscle Nerve; 2018 May; 57(5):814-820. PubMed ID: 29193204 [TBL] [Abstract][Full Text] [Related]
6. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis. Yilmaz V; Ulusoy C; Hajtovic S; Turkoglu R; Kurtuncu M; Tzartos J; Lazaridis K; Tuzun E Immunol Invest; 2021 Aug; 50(6):671-684. PubMed ID: 32597289 [TBL] [Abstract][Full Text] [Related]
7. Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Phillips WD; Christadoss P; Losen M; Punga AR; Shigemoto K; Verschuuren J; Vincent A Exp Neurol; 2015 Aug; 270():29-40. PubMed ID: 25542979 [TBL] [Abstract][Full Text] [Related]
9. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)]. Sanadze AG; Sidnev DV; Karganov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492 [TBL] [Abstract][Full Text] [Related]
10. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409 [TBL] [Abstract][Full Text] [Related]
11. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541 [TBL] [Abstract][Full Text] [Related]
12. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Duan RS; Adikari SB; Huang YM; Link H; Xiao BG Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302 [TBL] [Abstract][Full Text] [Related]
13. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice. Ulusoy C; Kim E; Tüzün E; Huda R; Yılmaz V; Poulas K; Trakas N; Skriapa L; Niarchos A; Strait RT; Finkelman FD; Turan S; Zisimopoulou P; Tzartos S; Saruhan-Direskeneli G; Christadoss P Clin Immunol; 2014 Apr; 151(2):155-63. PubMed ID: 24589747 [TBL] [Abstract][Full Text] [Related]
15. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586 [TBL] [Abstract][Full Text] [Related]
17. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188 [TBL] [Abstract][Full Text] [Related]
18. Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG). Chauhan M; Punga T; Punga AR Neurosci Res; 2013; 77(1-2):102-9. PubMed ID: 23933211 [TBL] [Abstract][Full Text] [Related]
19. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Richman DP; Nishi K; Morell SW; Chang JM; Ferns MJ; Wollmann RL; Maselli RA; Schnier J; Agius MA Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720 [TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement. Kusner LL; Sengupta M; Kaminski HJ Ann N Y Acad Sci; 2018 Feb; 1413(1):136-142. PubMed ID: 29356015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]